Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [(18)F]FDG PET

PURPOSE: Cerebral beta-amyloid and regional glucose metabolism assessed by positron emission tomography (PET) are used as diagnostic biomarkers for Alzheimer’s disease (AD). The present study validates the incremental diagnostic value of amyloid PET in addition to clinical diagnosis and [(18)F]FDG P...

Descripción completa

Detalles Bibliográficos
Autores principales: Hellwig, Sabine, Frings, Lars, Bormann, Tobias, Vach, Werner, Buchert, Ralph, Meyer, Philipp T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333717/
https://www.ncbi.nlm.nih.gov/pubmed/30094462
http://dx.doi.org/10.1007/s00259-018-4111-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333717/
https://www.ncbi.nlm.nih.gov/pubmed/30094462
http://dx.doi.org/10.1007/s00259-018-4111-3

Ejemplares similares